Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang; Carlos E. Bueso‐Ramos; Courtney DiNardo; Marcos R. Estecio; Masoud Davanlou; Q-R Geng; Zhihong Fang; Martin Nguyen; Sherry Pierce; Yue Wei; Simrit Parmar; Jörge E. Cortes; Hagop Kantarjian; Guillermo Garcia‐Manero

doi:10.1038/leu.2013.355

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang(The University of Texas MD Anderson Cancer Center), Carlos E. Bueso‐Ramos(The University of Texas MD Anderson Cancer Center), Courtney DiNardo(The University of Texas MD Anderson Cancer Center), Marcos R. Estecio(The University of Texas MD Anderson Cancer Center), Masoud Davanlou(The University of Texas MD Anderson Cancer Center), Q-R Geng(Sun Yat-sen University), Zhihong Fang(The University of Texas MD Anderson Cancer Center), Martin Nguyen(The University of Texas MD Anderson Cancer Center), Sherry Pierce(The University of Texas MD Anderson Cancer Center), Yue Wei(The University of Texas MD Anderson Cancer Center), Simrit Parmar(The University of Texas MD Anderson Cancer Center), Jörge E. Cortes(The University of Texas MD Anderson Cancer Center), Hagop Kantarjian(The University of Texas MD Anderson Cancer Center), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center)

Leukemia

November 25, 2013

10.1038/leu.2013.355

Cited by 679Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis